| |
| |
|
| Insider
Information: |
Steiner Mitchell Shuster |
| Relationship: |
President and CEO, Dir... |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
9,072,631 |
|
|
Indirect Shares
|
2,687,445 |
|
|
| Direct
Value |
$7,741,847 |
|
|
|
Indirect Value
|
$1,016,824 |
|
|
| Total
Shares |
11,760,076 |
|
|
| Total
Value |
$8,758,672 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-8.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -230.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oncternal Therapeutics Inc |
ONCT |
Chief Executive Office... |
2012-07-16 |
2,129,922 |
2012-07-16 |
2,543,445 |
Premium* |
|
|
Veru Inc |
VERU |
President and CEO, Dir... |
2024-05-24 |
6,942,709 |
2024-05-24 |
144,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-13 |
4 |
AS |
$10.82 |
$28,464 |
I/I |
(2,610) |
420,390 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-13 |
4 |
AS |
$10.83 |
$47,713 |
I/I |
(4,390) |
416,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-07 |
4 |
AS |
$10.84 |
$49,508 |
I/I |
(4,504) |
432,496 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-07 |
4 |
AS |
$10.85 |
$27,666 |
I/I |
(2,496) |
430,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-23 |
4 |
AS |
$10.87 |
$64,677 |
I/I |
(5,895) |
465,779 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-23 |
4 |
AS |
$10.88 |
$8,547 |
I/I |
(779) |
465,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-26 |
4 |
AS |
$11.07 |
$3,609 |
I/I |
(326) |
468,980 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-10 |
4 |
AS |
$11.11 |
$3,335 |
I/I |
(300) |
492,700 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-09 |
4 |
AS |
$11.14 |
$39,334 |
I/I |
(3,462) |
496,538 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-10 |
4 |
AS |
$11.15 |
$62,423 |
I/I |
(5,550) |
487,150 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-09 |
4 |
AS |
$11.16 |
$40,257 |
I/I |
(3,538) |
493,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-10 |
4 |
AS |
$11.18 |
$12,932 |
I/I |
(1,150) |
486,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2004-11-10 |
5 |
D |
$11.20 |
$818,160 |
I/I |
(73,050) |
291,081 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2004-11-10 |
5 |
A |
$11.20 |
$818,160 |
I/I |
73,050 |
4,970,206 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-16 |
4 |
AS |
$11.36 |
$63,862 |
I/I |
(5,499) |
480,501 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-16 |
4 |
AS |
$11.39 |
$20,611 |
I/I |
(1,776) |
477,443 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-06 |
4 |
AS |
$11.41 |
$71,670 |
I/I |
(6,189) |
437,811 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-04-06 |
4 |
AS |
$11.46 |
$9,389 |
I/I |
(811) |
437,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-17 |
4 |
AS |
$11.59 |
$54,189 |
I/I |
(4,643) |
472,000 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-03-17 |
4 |
AS |
$11.61 |
$24,436 |
I/I |
(2,082) |
476,643 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2006-12-21 |
4 |
S |
$18.20 |
$3,516,240 |
I/I |
(193,200) |
0 |
0 |
- |
|
| VERU |
Veru Inc |
President and CEO |
• • • |
2021-02-12 |
4 |
S |
$20.88 |
$417,688 |
I/I |
(20,000) |
190,000 |
0 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2007-03-14 |
4 |
S |
$22.10 |
$4,420,000 |
I/I |
(200,000) |
200,000 |
0 |
- |
|
148 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
